2018 Gastritis Drug Development - Pipeline Analysis - ResearchAndMarkets.com

July 12, 2018

DUBLIN--(BUSINESS WIRE)--Jul 12, 2018--The “2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report” report has been added to ResearchAndMarkets.com’s offering.

The Gastritis market presents robust business growth opportunity.

Around 20 companies and universities are focusing on developing treatment options for Gastritis.

To assist investigators and funding and regulatory organizations, the publisher has come up with a comprehensive report on Gastritis pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Gastritis pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Gastritis pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Key Topics Covered:

1 Gastritis (stomach inflammation) Pipeline Analysis

2 Gastritis (stomach inflammation) - Company Wise Pipeline Analysis

3 Gastritis (stomach inflammation) R&D Pipeline Snapshots

4 Recent Developments in Gastritis (stomach inflammation) Pipeline

5 Appendix

Companies Featured

Albireo AB Allakos, Inc. Arena Pharmaceuticals AstraZeneca Boryung Pharmaceutical Co Ltd CymaBay Therapeutics Daewoong Pharmaceutical Co. LTD. Enanta Pharmaceuticals FF Pharma Genfit Genkyotex GlaxoSmithKline Intercept Pharmaceuticals KAN Research Institute NGM Biopharmaceuticals Novartis Phenex Pharmaceuticals Recce Ltd RedHill Biopharma Ltd Retrophin Sequella Inc Suzhou Zelgen Biopharmaceutical Co Ltd Tiziana Life Sciences Trio Medicines Ltd Virobay Inc Zydus Cadila

For more information about this report visit https://www.researchandmarkets.com/research/65bnq7/2018_gastritis?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180712005426/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Discovery,Immune Disorders Drugs,Gastrointestinal Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/12/2018 08:28 AM/DISC: 07/12/2018 08:28 AM


Update hourly